Two CpG islands in the SEMA3B gene: Methylation in clear cell renal cell carcinoma

Molecular Biology

Volumn 43, Issue 6, 2009, Pages 1014-1018

  Loginov, V I ^a   Khodyrev, D S ^a   Pronina, I V ^a,b   Malyukova, A V ^a,c   Kazubskaya, T P ^d   Ermilova, V D ^d   Gar'kavtseva, R F ^d   Zabarovskii, E R ^b,c   Braga, E A ^a  

^a STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

^b ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^c KAROLINSKA INSTITUTE   (Sweden)

^d N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

Chromosome 3; Clear cell renal cell carcinoma; CpG islands; DNA methylation; mRNA level; Promoter region; SEMA3B gene

Indexed keywords

EID: 71449108922     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893309060156     Document Type: Article

References (14)

1. Tomizawa Y., Sekido Y., Kondo M., et al. 2001. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21. 3 candidate tumor suppressor gene SEMA3B. Proc. Natl. Acad. Sci. USA. 98, 13954-13959.
2. Tse C., Xiang R. H., Bracht T., Naylor S. L. 2002. Human Semaphorin 3B (SEMA3B) located at chromosome 3p21. 3 suppresses tumor formation in an adenocarcinoma cell line. Cancer Res. 62, 542-546.
3. Kisselev L. L., Senchenko V. N., Oparina N. Yu., Braga E. A., Zabarovsky E. R. 2005. Tumor suppressor genes localized on the short arm of human chromosome 3. Mol. Meditsina. 3, 17-28.
4. Kuroki T., Trapasso F., Yendamuri S., et al. 2003. Allelic loss on chromosome 3p21. 3 and promoter hypermethylation of Semaphorin 3B in non-small cell lung cancer. Cancer Res. 63, 3352-3355.
5. Ito M., Ito G., Kondo M., et al. 2005. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21. 3 by promoter hypermethylation and allele loss in non-small cell lung cancer. Cancer Lett. 225, 131-139.
6. Pronina I. V., Loginov V. I., Prasolov V. S., et al. 2009. Changes in the level of SEMA3B gene expression in epithelial tumors. Mol. Biol. 43, 439-445.
7. Braga E. A., Loginov V. I., Klimova E. A., et al. 2006. Activation of RHOA transcription in epithelial tumors may be caused by gene amplification and/or demethylation of the promoter region. Mol. Biol. 40, 865-877.
8. Khodyrev D. S., Loginov V. I., Pronina I. V., et al. 2008. Methylation of promoter region of RAR-2 gene in renal cell, breast, and ovarian carcinomas. Genetika. 44, 1126-1132.
9. Herman J. G., Graff J. R., Myohanen S., et al. 1996. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA. 93, 9821-9826.
10. Angeloni D. 2007. Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease. Brief Funct. Genomic Proteomic. 6, 19-39.
11. Hesson L. B., Cooper W. N., Latif F. 2007. Evaluation of the 3p21. 3 tumour-suppressor gene cluster. Oncogene. 26, 7283-7301.
12. Tischoff I., Markwarth A., Witzigmann H., et al. 2005. Allele loss and epigenetic inactivation of 3p21. 3 in malignant liver tumors. Int. J. Cancer. 115, 684-689.
13. Nair P. N., McArdle L., Cornell J., et al. 2007. High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene. Cancer Genet. Cytogenet. 174, 100-110.
14. Riquelme E., Tang M., Baez S., et al. 2007. Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma. Cancer Lett. 250, 100-106.